BlackRock Advisors’s ResMed RMD Stock Holding History

BlackRock Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$12.8M	Buy	205,878 +18,622	+10%	+$1.14M	0.01%	760
2016 Q3	$12.1M	Sell	187,256 -11,675	-6%	-$777K	0.01%	773
2016 Q2	$12.6M	Buy	198,931 +26,863	+16%	+$1.58M	0.01%	737
2016 Q1	$9.95M	Buy	172,068 +2,797	+2%	+$158K	0.01%	809
2015 Q4	$9.09M	Buy	169,271 +38,471	+29%	+$2.17M	0.01%	882
2015 Q3	$6.67M	Buy	130,800 +109,792	+523%	+$5.91M	0.01%	976
2015 Q2	$1.18M	Buy	21,008 +809	+4%	+$51.1K	﹤0.01%	1551
2015 Q1	$1.45M	Hold	20,199	–	–	﹤0.01%	1353
2014 Q4	$1.13M	Sell	20,199 -125	-0.6%	-$6.53K	﹤0.01%	1424
2014 Q3	$1M	Sell	20,324 -710	-3%	-$36.2K	﹤0.01%	1438
2014 Q2	$1.06M	Hold	21,034	–	–	﹤0.01%	1458
2014 Q1	$940K	Buy	21,034 +524	+3%	+$23.5K	﹤0.01%	1586
2013 Q4	$966K	Buy	20,510 +1,255	+7%	+$63.5K	﹤0.01%	1531
2013 Q3	$1.02M	Sell	19,255 -100,990	-84%	-$4.9M	﹤0.01%	1420
2013 Q2	$5.43M	Buy	+120,245	New	+$5.71M	0.01%	941

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Norges Bank Oslo, Norway $935B AUM

BlackRock Advisors's RMD Position: Q4 2016 in Review

BlackRock Advisors increased its ResMed (RMD) stake by 9.9% in Q4 2016, buying an estimated $1.14M and bringing the position to 205,878 shares worth $12.8M. The position accounts for 0.01% of the portfolio, ranked #760.

BlackRock Advisors first reported a position in RMD in Q2 2013 and has held it in 15 quarters since. 361 funds tracked by Wall St. Rank hold RMD as of Q4 2016.

BlackRock Advisors held 205,878 shares of ResMed worth $12.8M as of Q4 2016.
BlackRock Advisors bought 18,622 ResMed shares in Q4 2016, an estimated $1.14M.
ResMed made up 0.01% of BlackRock Advisors's portfolio in Q4 2016, its #760 holding.
BlackRock Advisors first reported a position in ResMed in Q2 2013 and has held it in 15 quarters since.
361 funds tracked by Wall St. Rank held ResMed as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.